PMID: 2126279Dec 1, 1990Paper

The role of tumour necrosis factor-alpha in acquired immunodeficiency syndrome

Journal of Internal Medicine
M Odeh

Abstract

Tumour necrosis factor-alpha (TNF) is a primary mediator in the pathogenesis of infection, tissue injury and inflammation. It is synthesised by various activated, phagocytic and non-phagocytic cells, and a wide variety of infectious or inflammatory stimulae are capable of triggering TNF biosynthesis. Recent studies indicate that overproduction of TNF in septicaemia is a critical step in triggering septic shock and multiple organ damage. Intravenous administration of recombinant human TNF induced the same types of derangement in cardiovascular homatologic, inflammatory and metabolic homeostasis that are found with endotoxic or septic shock. Chronic TNF production causes a potentially lethal syndrome of cachexia, anaemia, and protein and lipid wasting. Several investigators have recently demonstrated elevated levels of serum TNF in patients with acquired immunodeficiency syndrome (AIDS), these levels being closely correlated with the severity of the disease. This review discusses the role of TNF in the pathophysiology of AIDS and of several disorders associated with the latter. In addition, it discusses the interactions between TNF and several agents used in AIDS therapy, and suggests the use of TNF-antagonists in combination as ...Continue Reading

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
May 1, 1986·The Journal of Clinical Investigation·D D HoM S Hirsch
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J S PattonC Grunfeld
Jun 1, 1988·Journal of Neuroimmunology·E LaviS R Weiss
Mar 1, 1989·Clinical Immunology and Immunopathology·P Roux-LombardJ M Dayer
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G E GrauP Vassalli
Feb 1, 1989·Seminars in Arthritis and Rheumatism·M ShinmeiY Shimomura
Jan 1, 1989·Clinical Immunology and Immunopathology·Z F Rosenberg, A S Fauci
May 20, 1989·Lancet·K J TraceyA Cerami
Feb 1, 1989·Annals of the Rheumatic Diseases·I F Rowe, A C Keat
Jan 1, 1989·Scandinavian Journal of Rheumatology·C P Maury
May 1, 1989·Seminars in Arthritis and Rheumatism·L H Calabrese
Feb 1, 1989·Current Opinion in Immunology·K J Tracey, A Cerami
Mar 1, 1989·Journal of Applied Physiology·J JohnsonK L Brigham
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T M FolksA S Fauci
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P H HartJ A Hamilton
Aug 1, 1989·European Journal of Immunology·M RighiP Ricciardi-Castagnoli
Feb 1, 1989·Arthritis and Rheumatism·C P Maury, A M Teppo
Apr 1, 1988·The Journal of Experimental Medicine·D VercelliD Y Leung
Jul 1, 1986·The Journal of Immunology : Official Journal of the American Association of Immunologists·J K NicholsonJ S McDougal
Jul 11, 1986·Science·S GartnerM Popovic
Sep 1, 1986·Scandinavian Journal of Immunology·H NielsenV Faber

❮ Previous
Next ❯

Citations

Jan 1, 1993·Journal of Clinical Laboratory Analysis·M M Reddy, M H Grieco
Jun 19, 2008·Applied Microbiology and Biotechnology·Qiang ChenChundong Yu
Oct 15, 1996·Clinica Chimica Acta; International Journal of Clinical Chemistry·R M López GaleraJ M Tusell Puigbert
Feb 5, 2004·Brain, Behavior, and Immunity·Keith W Kelley
May 3, 2000·Clinical and Experimental Immunology·M A CalzadoE Muñoz
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·D F DarkoM M Mitler
May 1, 1992·Journal of Internal Medicine·M Odeh
Oct 1, 1994·Journal of Internal Medicine·M Odeh
Dec 22, 2010·Journal of Crohn's & Colitis·Syed F HabibI Salam
Feb 1, 1995·Medical Hypotheses·V Vincek
Oct 19, 2004·Molecular Immunology·Barbara WirleitnerDietmar Fuchs
Jan 1, 1996·International Journal of Health Services : Planning, Administration, Evaluation·A Walker, C K Wong
Aug 2, 2008·The Journal of Bone and Joint Surgery. British Volume·J RichardsonC B D Lavy
Nov 1, 1992·European Journal of Haematology·M Odeh
Sep 1, 1992·Clinical and Experimental Immunology·A KalinkovichZ Bentwich
Mar 1, 1995·European Journal of Haematology·V Calenda, J C Chermann
Sep 1, 1994·Infection and Immunity·D P DooleyD M Magee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.